F Viguié

Mutation in <i>TET2</i> in Myeloid Cancers

François Delhommeau, Sabrina Dupont, Véronique Della Valle et al. · New England Journal of Medicine · 2009 · 1.7K citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Atlas of Genetics and Cytogenetics in Oncology and Haematology in 2013

Jean‐Loup Huret, Mohammad Ahmad, Mélanie Arsaban et al. · Nucleic Acids Research · 2012 · 325 citations · Full text

Life Sciences, Genetics, Oncology +17

Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma

Frédéric Pène, Yann-Érick Claessens, O. Müller et al. · Oncogene · 2002 · 298 citations

Life Sciences, Cell Biology, Oncology +13

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok et al. · Blood · 2009 · 270 citations

Life Sciences, Genetics, Molecular Genetics +11

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation

Marina Bousquet, Cathy Quelen, Roberto Rosati et al. · The Journal of Experimental Medicine · 2008 · 248 citations · Full text

Medicine, Molecular Biology, Oncology +17